Evaluate Research provides institutional quality research on midcap equities on a global basis. The need for independent [non investment banking focused bulge bracket brokerage firms] company research is greater than ever before as brokerage firms and traditional sell-side research firms continue to shrink around the world. Our 30-page plus Initiation Reports evaluate in great details all aspects of publicly-traded companies: growth opportunities, catalysts, business description, competitive positioning, SWOT analysis, risks, etc. In addition, we determine specific price targets for all covered companies based on detailed 5-year complete forecasts of financial statements including IS, BS, CF, ratios, etc. Our price targets are supported by long-term DCF models. Finally, whereas many sell-side brokers offer sketchy and irregular ongoing maintenance research of companies, if not outright dropped or termination of coverage, at Evaluate Research we systematically monitor and regularly publish Update Notes covering quarterly earnings, major corporate events, etc.

All of our research reports are broadly disseminated globally on the leading investment information platforms including: Bloomberg, Thomson Reuters, S&P Capital IQ, FactSet, Morningstar etc. The reports will also be available on Evaluate’s own website. In addition, companies may choose to have the research report on their own website or as part of their ongoing shareholder communication and dissemination.

There are multiple benefits of having regular research coverage of public companies. Many institutional and retail investors will ignore and not invest in companies without research as they simply can’t commit the time and effort to “reinvent the wheel” and understand a company from scratch. This is especially true for mid-size companies. Institutional and even retail investors may not always agree with the opinion and price target on any research reports, but it still nonetheless helps them to quickly determine what the issues, critical variables, outlook, etc. are for a company. Research coverage can lead to higher liquidity, more access to capital [equity and debt] markets, a more fair stock price, more access to all sorts of investors [retail, domestic and foreign], increased visibility of the company and management, etc.

To ensure the highest ethical behavior, the firm has adopted globally recognized CFA Institute Standards for conduct and research. All of Evaluate’s research reports are written in-house by full-time dedicated staff. In addition, we have a team of independent advisors [Sandy Mehta, Larry Ioffredo, Glen Kleczka] with many years of investment experience at highly regarded global investment firms.